Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Jason Zemansky's Stock Ratings
B of A Securities Analyst
Jason Zemansky is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025
Updated: Dec 17, 2025
Overall Average Return
51.9%
Smart Score
Overall Average Return Percentile
94th
Number of Ratings
54
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/28/2025 | KROS | Buy Now | Keros Therapeutics | $20.83 | -8.79% | $18 → $19 | Maintains | Neutral | Get Alert | |
| 11/28/2025 | RCUS | Buy Now | Arcus Biosciences | $22.28 | 16.7% | $17 → $26 | Maintains | Neutral | Get Alert | |
| 11/18/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.30 | 142.42% | $10 → $8 | Maintains | Buy | Get Alert | |
| 11/18/2025 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 548.15% | $8 → $7 | Maintains | Buy | Get Alert | |
| 10/27/2025 | INSM | Buy Now | Insmed | $160.25 | 16.69% | $142 → $187 | Maintains | Buy | Get Alert | |
| 10/02/2025 | CYTK | Buy Now | Cytokinetics | $58.50 | -4.27% | $52 → $56 | Maintains | Neutral | Get Alert | |
| 08/25/2025 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 640.74% | $9 → $8 | Maintains | Buy | Get Alert | |
| 08/20/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.30 | 203.03% | $4 → $10 | Upgrade | Neutral → Buy | Get Alert | |
| 06/11/2025 | INSM | Buy Now | Insmed | $160.25 | -31.98% | $94 → $109 | Maintains | Buy | Get Alert | |
| 06/10/2025 | KROS | Buy Now | Keros Therapeutics | $20.83 | -13.59% | $32 → $18 | Downgrade | Buy → Neutral | Get Alert | |
| 05/28/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.30 | 172.73% | $32 → $9 | Maintains | Buy | Get Alert | |
| 04/15/2025 | CYTK | Buy Now | Cytokinetics | $58.50 | -7.69% | $62 → $54 | Maintains | Neutral | Get Alert | |
| 04/01/2025 | TVTX | Buy Now | Travere Therapeutics | $33.89 | -8.53% | $29 → $31 | Maintains | Buy | Get Alert | |
| 03/20/2025 | INSM | Buy Now | Insmed | $160.25 | -40.09% | $92 → $96 | Maintains | Buy | Get Alert | |
| 02/19/2025 | RCUS | Buy Now | Arcus Biosciences | $22.28 | -23.7% | $22 → $17 | Maintains | Neutral | Get Alert | |
| 11/22/2024 | KURA | Buy Now | Kura Oncology | $10.14 | 186% | $36 → $29 | Maintains | Buy | Get Alert | |
| 10/09/2024 | TVTX | Buy Now | Travere Therapeutics | $33.89 | -40.99% | $18 → $20 | Maintains | Buy | Get Alert | |
| 10/09/2024 | INSM | Buy Now | Insmed | $160.25 | -46.33% | $84 → $86 | Maintains | Buy | Get Alert | |
| 09/27/2024 | TVTX | Buy Now | Travere Therapeutics | $33.89 | -46.89% | $19 → $18 | Maintains | Buy | Get Alert | |
| 09/12/2024 | KROS | Buy Now | Keros Therapeutics | $20.83 | 264.86% | $81 → $76 | Maintains | Buy | Get Alert | |
| 09/06/2024 | TVTX | Buy Now | Travere Therapeutics | $33.89 | -43.94% | $18 → $19 | Maintains | Buy | Get Alert | |
| 08/15/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.37 | 52.18% | $30 → $31 | Maintains | Buy | Get Alert | |
| 08/09/2024 | RCUS | Buy Now | Arcus Biosciences | $22.28 | 3.23% | $24 → $23 | Maintains | Neutral | Get Alert | |
| 07/30/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.37 | 47.28% | $31 → $30 | Maintains | Buy | Get Alert | |
| 07/05/2024 | INSM | Buy Now | Insmed | $160.25 | -48.21% | $83 → $83 | Maintains | Buy | Get Alert | |
| 06/28/2024 | INSM | Buy Now | Insmed | $160.25 | -48.21% | $62 → $83 | Maintains | Buy | Get Alert | |
| 06/20/2024 | ESPR | Buy Now | Esperion Therapeutics | $3.65 | -31.51% | $2.9 → $2.5 | Downgrade | Neutral → Underperform | Get Alert | |
| 05/29/2024 | INSM | Buy Now | Insmed | $160.25 | -61.31% | $40 → $62 | Maintains | Buy | Get Alert | |
| 05/28/2024 | INSM | Buy Now | Insmed | $160.25 | -75.04% | $40 → $40 | Maintains | Buy | Get Alert | |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $58.50 | 2.56% | $70 → $60 | Maintains | Neutral | Get Alert | |
| 05/14/2024 | CYTK | Buy Now | Cytokinetics | $58.50 | 19.66% | $75 → $70 | Maintains | Neutral | Get Alert | |
| 02/23/2024 | INSM | Buy Now | Insmed | $160.25 | -75.04% | $37 → $40 | Maintains | Buy | Get Alert | |
| 01/30/2024 | RCUS | Buy Now | Arcus Biosciences | $22.28 | 12.21% | $23 → $25 | Maintains | Neutral | Get Alert | |
| 01/03/2024 | ESPR | Buy Now | Esperion Therapeutics | $3.65 | -31.51% | $4 → $2.5 | Downgrade | Buy → Neutral | Get Alert | |
| 12/26/2023 | ALVR | Buy Now | AlloVir | — | — | $17 → $1 | Downgrade | Buy → Underperform | Get Alert | |
| 10/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.37 | 42.37% | → $29 | Initiates | → Buy | Get Alert | |
| 09/06/2023 | INSM | Buy Now | Insmed | $160.25 | -76.91% | $35 → $37 | Maintains | Buy | Get Alert | |
| 09/05/2023 | RCUS | Buy Now | Arcus Biosciences | $22.28 | 3.23% | $21 → $23 | Maintains | Neutral | Get Alert | |
| 08/18/2023 | ALVR | Buy Now | AlloVir | — | — | → $17 | Initiates | → Buy | Get Alert | |
| 08/11/2023 | KURA | Buy Now | Kura Oncology | $10.14 | 205.72% | → $31 | Initiates | → Buy | Get Alert | |
| 07/03/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | → $23 | Initiates | → Buy | Get Alert | |
| 06/15/2023 | ESPR | Buy Now | Esperion Therapeutics | $3.65 | 9.59% | $1.25 → $4 | Upgrade | Underperform → Buy | Get Alert | |
| 05/12/2023 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 825.93% | $9 → $10 | Maintains | Buy | Get Alert | |
| 03/23/2023 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 733.33% | → $9 | Reiterates | Buy → Buy | Get Alert | |
| 03/16/2023 | ESPR | Buy Now | Esperion Therapeutics | $3.65 | -58.91% | $8 → $1.5 | Downgrade | Neutral → Underperform | Get Alert | |
| 02/27/2023 | ESPR | Buy Now | Esperion Therapeutics | $3.65 | 119.17% | → $8 | Reinstates | → Neutral | Get Alert | |
| 02/17/2023 | CYTK | Buy Now | Cytokinetics | $58.50 | -16.24% | → $49 | Initiates | → Neutral | Get Alert | |
| 01/30/2023 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 640.74% | $9 → $8 | Maintains | Buy | Get Alert | |
| 11/18/2022 | RCUS | Buy Now | Arcus Biosciences | $22.28 | 48.11% | → $33 | Initiates | → Neutral | Get Alert | |
| 11/18/2022 | INSM | Buy Now | Insmed | $160.25 | -75.66% | → $39 | Initiates | → Buy | Get Alert | |
| 02/22/2022 | FIXX | Buy Now | Homology Medicines | — | — | $25 → $9 | Maintains | Buy | Get Alert | |
| 12/13/2021 | ALLK | Buy Now | Allakos | — | — | $145 → $155 | Maintains | Buy | Get Alert | |
| 09/10/2021 | HOWL | Buy Now | Werewolf Therapeutics | $1.08 | 2307.41% | → $26 | Initiates | → Buy | Get Alert | |
| 01/15/2021 | ALLK | Buy Now | Allakos | — | — | → $145 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved